These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

136 related articles for article (PubMed ID: 9877115)

  • 21. [Organ protection by antihypertensive treatment. Also conceivable for kidney diseases?. Interview by Dr. med. Monika Flasnoecker].
    Mann J
    Fortschr Med; 1996 Nov; 114(32):15. PubMed ID: 9064261
    [No Abstract]   [Full Text] [Related]  

  • 22. [Possibilities of outpatient renoprotective therapy].
    Kolina IB; Stavrovskaia EV; Shilov EM
    Ter Arkh; 2005; 77(6):33-5. PubMed ID: 16078597
    [TBL] [Abstract][Full Text] [Related]  

  • 23. [Nephroprotection: how to slow the progression of chronic renal insufficiency?].
    Hannedouche T; Krummel T; Parvez-Braun L
    Nephrol Ther; 2005 May; 1(2):135-44. PubMed ID: 16895678
    [TBL] [Abstract][Full Text] [Related]  

  • 24. [The role of arterial hypertension in the progression of chronic renal failure].
    Kes P; Ratković-Gusić I; Sefer S
    Lijec Vjesn; 1996; 118(1-2):45-6. PubMed ID: 8759423
    [No Abstract]   [Full Text] [Related]  

  • 25. [Comparative assessment of the results of new antihypertensive drugs].
    Schubert R; Pasz T; Lindner O
    Munch Med Wochenschr; 1968 Jul; 110(27):1604-9. PubMed ID: 5756285
    [No Abstract]   [Full Text] [Related]  

  • 26. [A 100-year perspective on renal function and hypertension. Anti-renin therapy has made hypertensive renal failure a rarity].
    Bergström G; Herlitz H; Himmelmann A; Ljungman S; Aurell M
    Lakartidningen; 1999 Nov; 96(47):5209-14. PubMed ID: 10608112
    [TBL] [Abstract][Full Text] [Related]  

  • 27. [Slowing down the progression of chronic renal failure].
    Jacobs C
    Nephrol Ther; 2005 May; 1(2):81-3. PubMed ID: 16895671
    [No Abstract]   [Full Text] [Related]  

  • 28. Hypertension in human renal disease.
    Brown MA; Whitworth JA
    J Hypertens; 1992 Aug; 10(8):701-12. PubMed ID: 1325500
    [No Abstract]   [Full Text] [Related]  

  • 29. [Progressive renal failure. Why blood pressure must now be monitored].
    Tepel M; van der Giet M; Zidek W
    MMW Fortschr Med; 2000 Jun; 142(25):42-4. PubMed ID: 10920669
    [TBL] [Abstract][Full Text] [Related]  

  • 30. [Experience in the use of valsartan with the aim to inhibit progression of kidney failure in patients with chronic glomerulonephritis].
    Shvetsov MIu; Medvedeva TIu; Kozlovskaia NL; Miroshnichenko NG; Okonova EB; Shonichev DG; Rudenko TE; Stavrovskaia EV; Plieva OK
    Ter Arkh; 2001; 73(6):55-61. PubMed ID: 11521525
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Hypertension: a review and rationale of treatment.
    Copley JB; Rosario R
    Dis Mon; 2005; 51(10-11):548-614. PubMed ID: 16360376
    [No Abstract]   [Full Text] [Related]  

  • 32. [Hypertension in predialysis chronic renal insufficiency-- when and how to treat?].
    Switalski M
    Pol Arch Med Wewn; 2003 Oct; 110(4):1197-207. PubMed ID: 14699679
    [No Abstract]   [Full Text] [Related]  

  • 33. [Use of antibacterial, diuretic and antihypertensive drugs].
    Kokot F
    Przegl Lek; 1982; 39(7):469-80. PubMed ID: 7178518
    [No Abstract]   [Full Text] [Related]  

  • 34. [Antihypertensive therapy in early stages of chronic kidney disease. Second and third stages of chronic kidney disease].
    Gorostidi M; Marín R;
    Nefrologia; 2004; 24 Suppl(6):91-100, 187-235. PubMed ID: 15696900
    [No Abstract]   [Full Text] [Related]  

  • 35. Should beta-blockers be used to control hypertension in people with chronic kidney disease?
    Hart PD; Bakris GL
    Semin Nephrol; 2007 Sep; 27(5):555-64. PubMed ID: 17868793
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Effect of light exercise on renal hemodynamics in patients with hypertension and chronic renal disease.
    Svarstad E; Myking O; Ofstad J; Iversen BM
    Scand J Urol Nephrol; 2002; 36(6):464-72. PubMed ID: 12623513
    [TBL] [Abstract][Full Text] [Related]  

  • 37. [Debrisoquine sulfate, a new antihypertensive agent].
    Dieu Y
    Brux Med; 1970 Mar; 50(3):195-201. PubMed ID: 5446621
    [No Abstract]   [Full Text] [Related]  

  • 38. [On the evaluation of therapeutic effects in hypertension (described by the example of Guanoxan)].
    Siedek H; Klein K; Grübl M
    Munch Med Wochenschr; 1965 Oct; 107(43):2119-24. PubMed ID: 5899029
    [No Abstract]   [Full Text] [Related]  

  • 39. [On the antihypertensive activity of some drugs alone or in various associations].
    Anfossi F; Guaraggi A; Rossi PL
    Minerva Cardioangiol; 1966 Oct; 14(10):617-22. PubMed ID: 5996323
    [No Abstract]   [Full Text] [Related]  

  • 40. Effectiveness of antihypertensive treatment in patients with chronic kidney disease.
    Król E; Czarniak P; Rutkowski B
    J Ren Nutr; 2008 Jan; 18(1):134-9. PubMed ID: 18089460
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.